In this group, hormone receptor positivity may be of prognostic and therapeutic value since the ER and progesterone receptor (PR) are usually positive in low‐grade endometrioid carcinomas while the aggressive tumor types just listed are typically negative. This evidence concerns the gene PGR and neoplasm.